Roman Ivanov
JSC BIOCAD · JCS BIOCAD · Biocad
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
23
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
10
PubMed author-name match
Trials
Studies that name Roman Ivanov as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:55 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04060264 · Clinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal HemoglobinuriaBiocad · completed · Paroxysmal Nocturnal Hemoglobinuria · study chair
- Ph2NCT04056897 · Comparative Study of the Efficacy and Safety of BCD-132 With Teriflunomide and Placebo in Multiple SclerosisBiocad · completed · Multiple Sclerosis · study chair
- Ph1NCT03693950 · The Study of PK, PD, Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy VolunteersBiocad · completed · Healthy · study chair
- Ph3NCT03598751 · Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic ArthritisBiocad · completed · Psoriatic Arthritis · study chair
- Ph2NCT03519243 · Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on DialysisBiocad · completed · Anemia · study chair
- Ph2NCT03455842 · The BCD-089 (aIL6R) in Patients With Active Rheumatoid ArthritisBiocad · completed · Seropositive RA · study chair
- Ph3NCT03447704 · International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing SpondylitisBiocad · completed · Ankylosing Spondylitis · study chair
- Ph3NCT03390101 · An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque PsoriasisBiocad · completed · Moderate to Severe Plaque Psoriasis · study chair
- Ph1NCT02762799 · Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®Biocad · completed · Leucocytosis · study chair
- Ph2NCT02763111 · Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing SpondylitisBiocad · completed · Ankylosing Spondylitis · study chair
- Ph2
- Ph3NCT02762812 · Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing SpondylitisBiocad · completed · Ankylosing Spondylitis · study chair
- Ph3NCT02762838 · Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid ArthritisBiocad · completed · Rheumatoid Arthritis · study chair
- Ph3NCT02762955 · Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque PsoriasisBiocad · completed · Psoriasis · study chair
- Ph2/Ph3NCT02744222 · Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple SclerosisBiocad · completed · Multiple Sclerosis, Relapsing-Remitting · study chair
- Ph3NCT02744196 · Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid ArthritisBiocad · completed · Rheumatoid Arthritis · study chair
- Ph1NCT02731469 · Study of Pharmacokinetics, Pharmacodynamics, Safety of BCD-131 Compared to Mircera and Aranesp in Healthy VolunteersBiocad · completed · Reticulocyte Count · study chair
- Ph1NCT02450981 · Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular DegenerationBiocad · withdrawn · Neovascular Age-related Macular Degeneration · study chair
- Ph1NCT02395055 · Comparative Clinical Study of Pharmacokinetics, Tolerance and Safety of BCD-057 and Humira in Healthy VolunteersBiocad · completed · Healthy · study chair
- Ph1NCT02380287 · First-in-human Study to Evaluate Safety, Tolerability and Pharmacokinetics of Various Doses of BCD-085 in Healthy SubjectsBiocad · completed · Healthy · study chair
- Ph3NCT02104830 · Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer PatientsBiocad · completed · Chemotherapy-induced Neutropenia · study director
- Ph3NCT01764022 · A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer PatientsBiocad · completed · Human Epithelial Receptor (HER)-2 Positive Breast Cancer · study chair
- Ph3NCT01701232 · Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's LymphomaBiocad · completed · Follicular Non-Hodgkin's Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:55 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.Exp Hematol · 200836 citationsRCR 0.9
- Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults.Clin Exp Rheumatol · 202036 citationsRCR 1.6
- Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-022 with reference trastuzumab.BMC Cancer · 202013 citationsRCR 0.7
- A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study.Rheumatol Int · 201910 citationsRCR 0.5
- Proposed rituximab biosimilar BCD-020 versus reference rituximab for treatment of patients with indolent non-Hodgkin lymphomas: An international multicenter randomized trial.Hematol Oncol · 202010 citationsRCR 0.5
- [Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study].Zh Nevrol Psikhiatr Im S S Korsakova · 20169 citationsRCR 0.4
- [Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety].Zh Nevrol Psikhiatr Im S S Korsakova · 20195 citationsRCR 0.2
- [Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a].Zh Nevrol Psikhiatr Im S S Korsakova · 20192 citationsRCR 0.1
- [The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis].Zh Nevrol Psikhiatr Im S S Korsakova · 20191 citationsRCR 0.0
- [Efficacy and safety of a new dosage form of vitaprost (tablets coated with intestinally soluble cover) in patients with prostatic adenoma].Urologiia · 20070 citationsRCR 0.0